US Patent 10899800 Stabilized soluble pre-fusion RSV F polypeptides
All edits
Edits on 5 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+220 characters)
Article
Patent abstract
Described are stable pre-fusion respiratory syncitial virus (RSV) F polypeptides, immunogenic compositions comprising the polypeptides and uses thereof for the prevention and/or treatment of RSV infection.
Edits on 1 Nov, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 20 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 30 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
108998000
Date of Patent
January 26, 2021
0Patent Application Number
147869550
Date Filed
April 24, 2014
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
108998000
Date of Patent
January 26, 2021
0Patent Application Number
147869550
Date Filed
April 24, 2014
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 9 Feb, 2022
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 10899800 Stabilized soluble pre-fusion RSV F polypeptides
Infobox
Is a
Patent jurisdiction
Patent number
10899800
Date of patent
January 26, 2021
Patent application number
14786955
Date Filed
April 24, 2014
Patent primary examiner
Find more entities like US Patent 10899800 Stabilized soluble pre-fusion RSV F polypeptides
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
